Skip to content

Impacts of Touch-massage on the Experience of Patients With Chronic Pain: a Mixed Study.

Impacts of Touch-massage on the Experience of Patients With Chronic Pain and on the Provider-patient Relationship in Inpatient Settings: a Mixed Method Study.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04295603
Enrollment
82
Registered
2020-03-04
Start date
2019-10-01
Completion date
2021-06-30
Last updated
2023-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Pain

Keywords

Toucher-Massage, Well-being, Gratitude

Brief summary

The main purpose of this study is to evaluate the impacts of Toucher-Massage on the experience of patients with chronic pain. The study takes place in two rehabilitation internal medicine services of the University Hospitals of Geneva at 2 inpatients units with 78 participants (39 per group).

Detailed description

This is a monocentric study with a design of non-randomized cluster trial with an exploratory qualitative part. The treatment is assigned to one of two care units and subjects are allocated to the care unit not according to a randomization process but based on administrative basis. The main purpose of this study is to evaluate the impacts of Toucher-Massage (TM) on the experience of patients with chronic pain hospitalized in two rehabilitation internal medicine services. The main objective is to measure the effects of TM on the global impression of change of the perception of pain. The secondary objectives are: 1. Measure the effects on 1. the severity and impact of pain 2. anxiety/depression 3. caregiver-patient interaction 2. Explore the experiences of patients benefiting from TM 3. Explore perceptions, resistance, barriers and facilitators regarding the proposed interventions with the health care teams of the units. The population is patients suffering from chronic pain in two units of the internal medicine rehabilitation service at Beau-Séjour. The two units are similar in terms of care intake and populations cared for. The required sample size is 78 participants (39 per group)

Interventions

OTHERToucher Massage (TM) on the feet

The intervention for the Experimental Group (EG) includes a massage time of about 15 minutes (according to current Geneva Hospital practice) on the foot area. At least four sessions will be delivered and spread over two weeks. The TM will be provided by the care team. The training time for the workers corresponds to 2 times 2 hours. In order to be as close as possible to a standardized session, practitioners will benefit from an intervention guide.

OTHERHomedics HM MP RELEX 90 device

The Control Group (CG) will benefit from an intervention of identical duration. The treatment consists of a foot massage with a Homedics HM MP RELEX 90 device, a heat-free shiatsu program, which lasts about 15 minutes. The use of the Homedics device is no more a common treatment than the practice of Touch-Massage. TM involves a therapeutic relationship between caregiver and patient. It is for this reason that we need a comparator that should allow us to keep the aspect of the massage while decreasing the aspect of the therapeutic relationship and therefore offer us an adequate comparator.

Sponsors

School of Health Sciences Geneva
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Subject)

Intervention model description

Monocentric study with a design of non-randomized cluster trial. The treatment is assigned to one of two care units and subjects are allocated to the care unit not according to a randomization process but based on administrative basis.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Hospitalized for a minimum of two weeks * Suffering from chronic pain for more than 3 months * Having sufficient command of French in reading, writing or speaking

Exclusion criteria

* Documented cognitive impairments, and jeopardizing their ability to discern * Diagnosed with cancer that does interfere with foot massage (extremities metastases) * Dermatological conditions that interfere with foot massage * Suffering from major polyneuropathy * Taking anticoagulants or bleeding disorders * Being pregnant * Having a pacemaker

Design outcomes

Primary

MeasureTime frameDescription
Global impression of changeBaseline, two weeksGlobal impression of change will be measured by The Patient Global Impression of Change (PGIC). Minimum value = 1 (no change or condition has got worse) Maximum value = 7 (a great deal better, and a considerable improvement that has made all the difference)

Secondary

MeasureTime frameDescription
Severity of painBaseline, two weeksThe Brief Pain Inventory (BPI) assesses the severity of pain and the impact on activities. The scale contains nine items: four of which have a numerical assessment scale for pain severity ranging from 0-10 (0= no pain and 10 representing the strongest possible). The impact of pain is assessed on general activity activities, mood, walking ability, work, relationships, sleep, and taste for life (0= does not interfere, 10= gene completely). The scale provides two main scores: a severity score and a pain repercussions score.
Anxiety, depressionBaseline, two weeksThe Hospital Anxiety and Depression Scale (HADS) is composed of seven items measuring anxiety, and seven items concerning depression. Minimum value= 0 (never) Maximum value = 3 (really very often). A score greater than or equal to 11 indicates that the person is suffering from anxiety or depression.
The patient's perception of their interaction with the caregiverBaseline, two weeksThe Nurse-Patient-Interaction Scale (NPIS) questionnaire will be used to assess the patient's perception of interaction with caregivers across 14 items. Minimum value = 1 (not at all) Maximum value = 10 (a lot). The higher the score, the better the interaction with caregivers.

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 25, 2026